Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Terminated × Thoracic Neoplasms × Clear all

Phase

Phase 1 5 Phase 3 3 Phase 2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 4 1

Status

Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Neoplasms 16 Prostatic Neoplasms 12 Neoplasm Metastasis 10 Pain 9 Colorectal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Lung Neoplasms 8 Polycystic Ovary Syndrome 7 Leiomyoma 6 Anemia 5 Skin Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Leukemia 4 Carcinoma, Renal Cell 4 Recurrence 3 Melanoma 3 Liver Neoplasms 3 Kidney Neoplasms 3 Keratosis, Actinic 3 Insulin Resistance 3 Carcinoma, Hepatocellular 3 Cancer Pain 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Stomach Neoplasms 2

Interventions

Vinorelbine 1 Pemetrexed 1 Paclitaxel 1 Nivolumab 1 Gemcitabine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05583188 2024-07-19

VIGOR

Galvanize Therapeutics, Inc.

Phase 4 Terminated

Lung Diseases, Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡